NO20020291L - Terapeutiske og profylaktiske midler for neoplasmer - Google Patents
Terapeutiske og profylaktiske midler for neoplasmerInfo
- Publication number
- NO20020291L NO20020291L NO20020291A NO20020291A NO20020291L NO 20020291 L NO20020291 L NO 20020291L NO 20020291 A NO20020291 A NO 20020291A NO 20020291 A NO20020291 A NO 20020291A NO 20020291 L NO20020291 L NO 20020291L
- Authority
- NO
- Norway
- Prior art keywords
- therapeutic
- prophylactic agents
- neoplasms
- thiazolidin
- ylmethyl
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 230000000069 prophylactic effect Effects 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
- -1 thiazolidin-2,4-dione-5-ylmethyl Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20447699 | 1999-07-19 | ||
| PCT/JP2000/004858 WO2001005402A1 (fr) | 1999-07-19 | 2000-07-19 | Agents preventifs et therapeutiques du cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20020291D0 NO20020291D0 (no) | 2002-01-18 |
| NO20020291L true NO20020291L (no) | 2002-03-18 |
Family
ID=16491170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20020291A NO20020291L (no) | 1999-07-19 | 2002-01-18 | Terapeutiske og profylaktiske midler for neoplasmer |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6569877B2 (cs) |
| EP (1) | EP1197211A4 (cs) |
| KR (1) | KR20020015383A (cs) |
| CN (1) | CN1374864A (cs) |
| AU (1) | AU760917B2 (cs) |
| BR (1) | BR0012591A (cs) |
| CA (1) | CA2379662A1 (cs) |
| CZ (1) | CZ2002178A3 (cs) |
| HU (1) | HUP0202340A3 (cs) |
| IL (1) | IL147593A0 (cs) |
| MX (1) | MXPA02000757A (cs) |
| NO (1) | NO20020291L (cs) |
| NZ (1) | NZ516636A (cs) |
| PL (1) | PL352681A1 (cs) |
| RU (1) | RU2219928C2 (cs) |
| TR (1) | TR200200111T2 (cs) |
| WO (1) | WO2001005402A1 (cs) |
| ZA (1) | ZA200200316B (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI284533B (en) * | 1999-05-24 | 2007-08-01 | Sankyo Co | Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant |
| RU2278681C1 (ru) * | 2005-01-24 | 2006-06-27 | Открытое акционерное общество "Нижегородский химико-фармацевтический завод" | Средство для лечения заболеваний предстательной железы |
| US9092523B2 (en) | 2005-02-28 | 2015-07-28 | Search Engine Technologies, Llc | Methods of and systems for searching by incorporating user-entered information |
| CN101523338B (zh) | 2005-03-18 | 2016-10-19 | 搜索引擎科技有限责任公司 | 应用来自用户的反馈来改进搜索结果的搜索引擎 |
| WO2007100027A1 (ja) * | 2006-03-02 | 2007-09-07 | Daiichi Sankyo Company, Limited | 光学活性なチアゾリジンジオン誘導体 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3152992B2 (ja) * | 1992-04-03 | 2001-04-03 | 株式会社興人 | 過酸化脂質の生成抑制及び消去用組成物 |
| EP0805155B1 (en) * | 1994-09-28 | 2002-03-13 | Nippon Suisan Kaisha, Ltd. | Novel antioxidant tricyclic fused heterocyclic compound |
| TW403748B (en) * | 1994-11-02 | 2000-09-01 | Takeda Chemical Industries Ltd | An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same |
| JP3820601B2 (ja) * | 1995-03-27 | 2006-09-13 | 大塚製薬株式会社 | 活性酸素消去剤 |
| CZ293016B6 (cs) * | 1995-06-01 | 2004-01-14 | Sankyo Company Limited | Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem |
| US5814647A (en) * | 1997-03-04 | 1998-09-29 | Board Of Regents, The University Of Texas System | Use of troglitazone and related compounds for the treatment of the climacteric symptoms |
| CN1255386C (zh) * | 1997-10-08 | 2006-05-10 | 三共株式会社 | 有取代稠合杂环化合物 |
| WO1999030739A1 (fr) * | 1997-12-16 | 1999-06-24 | Sankyo Company, Limited | Remede contre la leucemie |
| US6878896B2 (en) * | 2002-07-24 | 2005-04-12 | United Parcel Service Of America, Inc. | Synchronous semi-automatic parallel sorting |
-
2000
- 2000-07-19 BR BR0012591-1A patent/BR0012591A/pt not_active IP Right Cessation
- 2000-07-19 AU AU60212/00A patent/AU760917B2/en not_active Ceased
- 2000-07-19 TR TR2002/00111T patent/TR200200111T2/xx unknown
- 2000-07-19 HU HU0202340A patent/HUP0202340A3/hu unknown
- 2000-07-19 MX MXPA02000757A patent/MXPA02000757A/es active IP Right Grant
- 2000-07-19 RU RU2002101136/14A patent/RU2219928C2/ru not_active IP Right Cessation
- 2000-07-19 EP EP00946418A patent/EP1197211A4/en not_active Withdrawn
- 2000-07-19 WO PCT/JP2000/004858 patent/WO2001005402A1/ja not_active Application Discontinuation
- 2000-07-19 IL IL14759300A patent/IL147593A0/xx unknown
- 2000-07-19 CZ CZ2002178A patent/CZ2002178A3/cs unknown
- 2000-07-19 PL PL00352681A patent/PL352681A1/xx not_active Application Discontinuation
- 2000-07-19 KR KR1020027000804A patent/KR20020015383A/ko not_active Ceased
- 2000-07-19 CN CN00813067A patent/CN1374864A/zh active Pending
- 2000-07-19 CA CA002379662A patent/CA2379662A1/en not_active Abandoned
- 2000-07-19 NZ NZ516636A patent/NZ516636A/en unknown
-
2002
- 2002-01-14 ZA ZA200200316A patent/ZA200200316B/en unknown
- 2002-01-18 NO NO20020291A patent/NO20020291L/no not_active Application Discontinuation
- 2002-01-18 US US10/053,136 patent/US6569877B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001005402A1 (fr) | 2001-01-25 |
| AU760917B2 (en) | 2003-05-22 |
| PL352681A1 (en) | 2003-09-08 |
| ZA200200316B (en) | 2003-06-25 |
| EP1197211A4 (en) | 2004-09-01 |
| IL147593A0 (en) | 2002-08-14 |
| RU2219928C2 (ru) | 2003-12-27 |
| CA2379662A1 (en) | 2001-01-25 |
| HUP0202340A2 (hu) | 2003-02-28 |
| CN1374864A (zh) | 2002-10-16 |
| MXPA02000757A (es) | 2002-07-22 |
| US20020137776A1 (en) | 2002-09-26 |
| TR200200111T2 (tr) | 2002-08-21 |
| HUP0202340A3 (en) | 2006-03-28 |
| CZ2002178A3 (cs) | 2002-05-15 |
| EP1197211A1 (en) | 2002-04-17 |
| BR0012591A (pt) | 2002-04-09 |
| AU6021200A (en) | 2001-02-05 |
| NO20020291D0 (no) | 2002-01-18 |
| NZ516636A (en) | 2004-01-30 |
| KR20020015383A (ko) | 2002-02-27 |
| US6569877B2 (en) | 2003-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052038L (no) | Ny adeninforbindelse og anvendelse derav | |
| NO20031561L (no) | Kjemiske forbindelser | |
| NO20061076L (no) | (Tio)karbamoylsykloheksanderivater som D3/D2 -reseptorantagonister | |
| IS7170A (is) | Bensóþíasepín og bensóþíadíasepínafleiður með tálmavirkni gegn dausgarnargallsýruflutningi (ileal bile acid transport, IBAT) til að meðhöndla fitudreyra | |
| DK1323710T3 (da) | Nitrogenholdige femleddede ringforbindelser | |
| PL373888A1 (en) | 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides | |
| FI942635A0 (fi) | Piperatsiinijohdannaiset 5HT1A-antagonisteina | |
| ATE205484T1 (de) | Aminotetrazol-derivate verwendbar als stickstoff- oxid-synthase inhibitoren | |
| DE69122941D1 (de) | Piperazinderivate | |
| NO983493L (no) | Nye benzimidazol-, benzoksazol- og benzotiazolforbindelser, fremgangsmÕte ved fremstilling derav og farmas°ytiske sammensetninger inneholdende slike | |
| NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
| NO20000722L (no) | 2-(4-aryl eller heteroaryl-piperazin-1-ylmetyl)-1H- indolderivater | |
| DE69725585D1 (de) | Phenylalkylcarbonsäure-derivate | |
| NZ516100A (en) | Streptogramin derivatives, preparation and compositions containing them | |
| IL108258A0 (en) | Piperazine derivates, their preparation and pharmaceutical compositions containing them | |
| NO20020291L (no) | Terapeutiske og profylaktiske midler for neoplasmer | |
| NZ517315A (en) | New derivatives of A-500359 | |
| DE60045821D1 (de) | Derivate von aromatische heterocyclen enthaltende integraseinhibitoren | |
| ATE275572T1 (de) | Malto-oligosaccharid-derivate und ihre anwendungen | |
| NO20012943L (no) | Nye heterocykliske forbindelser og farmasöytiske sammensetninger inneholdende det samme | |
| NO20013921L (no) | Heterocykliske derivater som inhibitorer av faktor Xa | |
| MXPA05007497A (es) | Derivados de acidos indenocarboxilicos y su uso para el tratamiento y prevencion de diabetes y dislipidemia. | |
| NO20020886L (no) | Nye integrin- <alfa>v<beta>3-inhibitorer | |
| NZ504299A (en) | 1-aza-2-alkyl-6-aryl-cycloalkane compounds, a process for their preparation and pharmaceutical compositions containing them | |
| EP1201664A4 (en) | BEMZIMIDAZOLE COMPOUNDS AND DRUGS CONTAINING THEM |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |